Xilio Therapeutics files beneficial ownership Form 3 for Chief Medical Officer Yariv Houvras
XLO•Xilio Therapeutics filed an initial Form 3 for Chief Medical Officer Yariv Houvras dated Sept. 28, 2026.
1. Form 3 filing
Xilio Therapeutics filed an initial Form 3 for Chief Medical Officer Yariv Houvras dated Sept. 28, 2026.
